CEVA INC (CEVA) Stock Analyst Ratings
NASDAQ:CEVA - Nasdaq - US1572101053 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 82% to CEVA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 37.91. This target is 16.9% above the current price.
CEVA was analyzed by 12 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about CEVA.
In the previous month the buy percentage consensus was at a similar level.
CEVA was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-14 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-02-14 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-11 | Rosenblatt | Maintains | Buy -> Buy |
| 2024-12-23 | Northland Capital Markets | Maintains | Outperform -> Outperform |
| 2024-11-08 | Roth MKM | Maintains | Buy -> Buy |
| 2024-11-08 | Rosenblatt | Maintains | Buy -> Buy |
| 2024-10-31 | Rosenblatt | Maintains | Buy -> Buy |
| 2024-08-08 | Roth MKM | Upgrade | Neutral -> Buy |
| 2024-08-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-10 | Roth MKM | Maintains | Neutral -> Neutral |
| 2024-02-13 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-12-07 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-08-11 | Barclays | Maintains | Overweight -> Overweight |
| 2023-08-10 | Roth MKM | Downgrade | Buy -> Neutral |
| 2023-08-10 | Rosenblatt | Maintains | Buy -> Buy |
| 2023-08-10 | Barclays | Maintains | Overweight -> Overweight |
| 2023-08-10 | Northland Capital Markets | Maintains | Outperform -> Outperform |
| 2023-05-11 | TD Cowen | Maintains | Outperform |
| 2023-05-11 | Roth MKM | Maintains | Buy |
| 2023-05-11 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-05-11 | Barclays | Maintains | Overweight -> Overweight |
| 2023-02-17 | Barclays | Maintains | Overweight |
| 2023-02-16 | Rosenblatt | Reiterate | Buy |
| 2023-02-16 | Cowen & Co. | Maintains | Outperform |
| 2023-02-14 | Rosenblatt | Reiterate | Buy |
| 2022-11-11 | Barclays | Maintains | Overweight |
| 2022-11-10 | Rosenblatt | Maintains | Buy |
| 2022-02-16 | Rosenblatt | Upgrade | Neutral -> Buy |
| 2021-06-23 | Rosenblatt | Initiate | Neutral |
| 2021-05-11 | Barclays | Upgrade | Equal-Weight -> Overweight |